---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272327788.md"
description: "ZHIFEI-BIOL expects a net loss attributable to shareholders of the listed company of RMB 10.6979361 billion to RMB 13.7256538 billion in 2025, compared to a profit of RMB 2.0184785 billion in the previous year"
datetime: "2026-01-12T22:44:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272327788.md)
  - [en](https://longbridge.com/en/news/272327788.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272327788.md)
---

# 

ZHIFEI-BIOL expects a net loss attributable to shareholders of the listed company of 10.6979361 billion to 13.7256538 billion yuan in 2025, compared to a profit of 2.0184785 billion yuan in the previous year

### Related Stocks

- [300122.CN](https://longbridge.com/en/quote/300122.CN.md)

## Related News & Research

- [DJI’s e-bike division tries to defend why its motors are so insanely powerful](https://longbridge.com/en/news/286894898.md)
- [ZAWYA: Joramco rewards employees with up to 12 weeks’ bonus](https://longbridge.com/en/news/287035395.md)
- [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md)
- [Seegene Launches Allplex™ MDRO Assay Under IVDR: Expanding AMR Testing Portfolio in Europe](https://longbridge.com/en/news/287237973.md)
- [13:00 ETBucked Up® Launches Summer Lemonades: Three Limited Edition Pre-Workout Flavors Built for the Season](https://longbridge.com/en/news/287099042.md)